Who is affected and how:

• People seeking fertility treatment (including users of assisted reproductive technology) will have expanded protections when their individual or small‑group plan covers fertility care: they cannot be denied coverage just because they lack a formal infertility diagnosis, and cost‑sharing and limits must be no less favorable than for other medical/surgical benefits. This increases access for single people, same‑sex couples, and others excluded by traditional infertility definitions.

• Health insurance issuers and plan administrators offering fertility benefits in the individual and small‑group markets will face new regulatory requirements: they must align cost‑sharing and quantitative limits with other medical benefits, change policies that deny coverage for lack of diagnosis, and perform analyses and submit reports on utilization management. These obligations will create administrative work and compliance costs.

• Employers that sponsor small‑group plans will be affected if their plans offer fertility coverage, because plan designs and member communications may need revision; large‑group and self‑insured employer plans are not explicitly covered by this provision as described.

• Consumers may see modest premium changes if expanded coverage and reduced utilization controls raise costs, though effects will vary by market, state rules, and how issuers set premiums. Increased transparency from issuer reporting could inform regulators and policymakers about barriers and utilization trends.

• Health equity: the rule reduces categorical barriers tied to infertility diagnoses, helping populations historically less likely to meet standard infertility criteria (including some racial/ethnic groups, LGBTQ+ individuals, and single prospective parents).

• Legal/regulatory interplay: state benefit mandates, existing essential health benefit baselines, and ERISA-covered plans could affect how the change is implemented; regulators will need to issue guidance on scope and compliance.